Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP176495.RAYA1Wdp6nfHfRFMl0qgFWwRl6Si6TqQMICJJQz8nyyuo130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176495.RAYA1Wdp6nfHfRFMl0qgFWwRl6Si6TqQMICJJQz8nyyuo130_provenance.
• NP262872.RAkQBhc-BcM4Mf9-cKqXFDtqRXlqCQB_tEfoZ8X5eqH3M130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262872.RAkQBhc-BcM4Mf9-cKqXFDtqRXlqCQB_tEfoZ8X5eqH3M130_provenance.
• NP900778.RAQl-HMFgwMcedLJaEqnq1JwKiDkw0RZMtlXg7CzmNTEg130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900778.RAQl-HMFgwMcedLJaEqnq1JwKiDkw0RZMtlXg7CzmNTEg130_provenance.
• NP450606.RAqA61hdOGzoBikTj8DoAYqjXoYo7cUcOp3EvYEhbzjhg130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450606.RAqA61hdOGzoBikTj8DoAYqjXoYo7cUcOp3EvYEhbzjhg130_provenance.
• NP936807.RAu9SDd9kMxTb7jt6lDu2Xxs4R_CbalhqyJqJmEjpjiwk130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936807.RAu9SDd9kMxTb7jt6lDu2Xxs4R_CbalhqyJqJmEjpjiwk130_provenance.
• assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP507986.RA7KDgtboXBmsoPXdRoH4H0Ux9vlH8E4DBWZPfpS9X1fc130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507986.RA7KDgtboXBmsoPXdRoH4H0Ux9vlH8E4DBWZPfpS9X1fc130_provenance.
• NP271803.RAQbcQHlbBqFlrn50bhLN8yWF6kLAO3XE3lJFRAzA-gGM130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271803.RAQbcQHlbBqFlrn50bhLN8yWF6kLAO3XE3lJFRAzA-gGM130_provenance.
• NP670618.RAXMC2rddPAX4xL5rzKZtEEINkDZR7uRxR_p-mGqa9CqM130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670618.RAXMC2rddPAX4xL5rzKZtEEINkDZR7uRxR_p-mGqa9CqM130_provenance.
• NP653202.RASUM0UZSWu4STRgkSaxHzqTywKYLnH2PNUmtkQ0vQInc130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653202.RASUM0UZSWu4STRgkSaxHzqTywKYLnH2PNUmtkQ0vQInc130_provenance.
• NP788474.RAb16dBkQd9iBcNkmQUjhL65M_Onq68b6hGaXTQ09zQhw130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788474.RAb16dBkQd9iBcNkmQUjhL65M_Onq68b6hGaXTQ09zQhw130_provenance.
• NP575807.RAF5c7LurzforjAwkOKPvuj6Pyp9P_3PL562AJZGegJcM130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575807.RAF5c7LurzforjAwkOKPvuj6Pyp9P_3PL562AJZGegJcM130_provenance.
• assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP979705.RARjhLPE83gp72Ggj_KniYJ1yF7XwdgR1GpVK9d2U9yLo130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979705.RARjhLPE83gp72Ggj_KniYJ1yF7XwdgR1GpVK9d2U9yLo130_provenance.
• NP652942.RAkS8cFsyKx49fkiOtq4ZjbiXpsU4jKGHqYnTrNog20Rc130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652942.RAkS8cFsyKx49fkiOtq4ZjbiXpsU4jKGHqYnTrNog20Rc130_provenance.
• NP979703.RAnDsGqDmBb4XU_xi5BGhzj4vNqqGUYcXgST_nsACqxfU130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979703.RAnDsGqDmBb4XU_xi5BGhzj4vNqqGUYcXgST_nsACqxfU130_provenance.
• NP979706.RAjqRCxJNtbi7A4jxzndbcWFBXOo557KJwjDwCcLgAqT8130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979706.RAjqRCxJNtbi7A4jxzndbcWFBXOo557KJwjDwCcLgAqT8130_provenance.
• NP979707.RAr7sTqexmqpIyPlzKX6mkxCD8jaSOSR2qvCU7TBMWNgw130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979707.RAr7sTqexmqpIyPlzKX6mkxCD8jaSOSR2qvCU7TBMWNgw130_provenance.
• NP392464.RA7rgLbBBGXwBdQDUIU2wfoX8-7Tf0sQffykwkSPaNfmA130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392464.RA7rgLbBBGXwBdQDUIU2wfoX8-7Tf0sQffykwkSPaNfmA130_provenance.
• NP979704.RANmC1Q1uwz8BrZjwg42ZUbTgyyozJktl8bT60qdn8WRA130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979704.RANmC1Q1uwz8BrZjwg42ZUbTgyyozJktl8bT60qdn8WRA130_provenance.
• NP979708.RA0l2mrIPgL0ohDTBJ-Bfr7QqUGU0ND1-aBywwXf4n83A130_assertion description "[However, in oncogene-positive cases (BRAF(V600E) and RET/PTC1), tumors with CNA/UPD were less frequent (5/15, 33%), whereas tumors with CNA/UPD were more frequent in oncogene-negative cases (7/10, 70%), suggesting that chromosomal aberrations may play a role in the development of PTC, especially in oncogene-negative tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979708.RA0l2mrIPgL0ohDTBJ-Bfr7QqUGU0ND1-aBywwXf4n83A130_provenance.